List view / Grid view
Researchers have developed a fluorescing nanoparticle capable of finding tumours, lighting up upon arrival and being activated with light to generate heat to destroy the cancer cells...
Scientists have found a way to effectively stop internal bleeding by magnetically-driven nanoparticles containing thrombin...
New injectable delivery system can slowly release drug carriers for months...
Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity...
The small normal Raman cross-section of glucose is a major challenge in its detection by surface enhanced Raman spectroscopy (SERS) for medical applications, such as blood glucose level monitoring of diabetic patients and evaluation of patients with other medical conditions, since glucose is a marker for many human diseases. Here…
Researchers have developed tiny drug-laden nanoparticles that can seek and destroy cancer stem cells...
Researchers have discovered properties of the precious metal that allow catalytic abilities to be accessed in living things without any side effects...
A research team formed have tested a new non-toxic contrast agent for magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) that could be superior to the current dye, gadolinium.
A hypoallergenic electronic sensor can be worn on the skin continuously for a week without discomfort, and is so light and thin that users forget they even have it on, says a Japanese group of scientists.
Join Precision NanoSystems for its second annual nanomedicines symposium...
European Pharmaceutical Review, Issue 2 of 2016 focused on nanotechnology and stem cell technology to monitor glucose and prevent diabetes, respectively. The aim of this review is to sensitise the technology innovators in this field by providing expert opinions on biomedical products and technologies that have come the closest so…
29 March 2017 | By Precision NanoSystems
Precision NanoSystems NanoAssemblr™ platform has been selected for the controlled manufacture of nanomedicines as part of the multinational B-SMART (Brain-Specific, Modular and Active RNA Therapeutics) translational research project...
15 March 2017 | By Steve Bremer, Managing Editor
Tumour therapy, particularly in the case of multidrug resistant cancers, could be significantly enhanced by using siRNA to down-regulate the production...
How sensitive spectroscopy tools can help identify substances linked to honeybee population decline...
12 October 2016 | By Particle Works
Particle Works – the nano- and microstructured material specialist – provides microencapsulation services for drug development applications, including controlled drug release, solubility enhancement or targeted drug delivery...
